Cooper Companies (COO) Stock Overview
Develops, manufactures, and markets contact lens wearers. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for COO from our risk checks.
COO Community Fair Values
Create NarrativeSee what 28 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
The Cooper Companies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$59.61 |
| 52 Week High | US$89.83 |
| 52 Week Low | US$58.89 |
| Beta | 0.89 |
| 1 Month Change | -14.92% |
| 3 Month Change | -27.25% |
| 1 Year Change | -27.23% |
| 3 Year Change | -38.88% |
| 5 Year Change | -39.56% |
| Change since IPO | 672.84% |
Recent News & Updates
Narrative Update • Apr 25
COO: Future Returns Will Rely On Ongoing Share Repurchases
Analysts have kept their price target for Cooper Companies broadly steady at about $91 per share. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E that together point to a similar view of the stock's underlying value.Narrative Update • Apr 09
COO: Future Returns Will Depend On Ongoing Buybacks And Myopia Management
Analysts have trimmed their price target for Cooper Companies by about $0.73, reflecting slightly updated views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Cooper Companies reports completing a share repurchase of 1,126,600 shares, or 0.58% of its outstanding stock, for $92.43m between November 1, 2025 and January 31, 2026 under its existing buyback program.Recent updates
Narrative Update • Apr 25
COO: Future Returns Will Rely On Ongoing Share Repurchases
Analysts have kept their price target for Cooper Companies broadly steady at about $91 per share. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E that together point to a similar view of the stock's underlying value.Narrative Update • Apr 09
COO: Future Returns Will Depend On Ongoing Buybacks And Myopia Management
Analysts have trimmed their price target for Cooper Companies by about $0.73, reflecting slightly updated views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Cooper Companies reports completing a share repurchase of 1,126,600 shares, or 0.58% of its outstanding stock, for $92.43m between November 1, 2025 and January 31, 2026 under its existing buyback program.Narrative Update • Mar 26
COO: Future Returns Will Rely On Myopia Management And Persistent Buybacks
Analysts have raised their price target for Cooper Companies slightly, to $91.80 from $91.25, citing updated assumptions around the discount rate, revenue growth, profit margin and future P/E levels. What's in the News Cooper Companies updated its fiscal 2026 earnings guidance, with total revenue projected in a range of $4.306b to $4.346b, described as organic growth of 4.5% to 5.5% (Corporate guidance).Narrative Update • Mar 12
COO: Future Returns Will Rely On Myopia Management Expansion And Buyback Discipline
Analysts have nudged their price target for Cooper Companies to $91.25 from $91.00, reflecting updated views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Cooper Companies updated its fiscal 2026 earnings outlook, guiding total revenue to a range of US$4.306b to US$4.346b with organic growth of 4.5% to 5.5% (Corporate guidance).Narrative Update • Feb 25
COO: Future Returns Will Depend On Myopia Management And Capital Allocation Review
Analysts have maintained their $91.00 price target on Cooper Companies, citing largely unchanged assumptions for revenue growth, profit margin, discount rate, and future P/E. Taken together, these factors indicate a similar view of the stock's long term value compared with prior estimates.Seeking Alpha • Feb 13
Moderating Growth Could Be A Tough Challenge For Cooper Shares
Summary Cooper Companies faces moderating revenue growth and margin leverage despite strong execution and market share gains in contact lenses and myopia management. A comprehensive strategic review is underway, with all options—including divestitures and business splits—on the table to unlock shareholder value. Myopia management (MiSight) offers a robust growth runway, but broader Vision and Surgical segments face pricing and competitive headwinds. COO is modestly undervalued (5%-10%), but limited catalysts and moderating market growth constrain the potential for a meaningful rerating. Read the full article on Seeking AlphaNarrative Update • Feb 09
COO: Future Returns Will Rely On Myopia Management And Capital Review Outcomes
Narrative Update on Cooper Companies Analysts have trimmed their price target on Cooper Companies slightly, now anchoring it around an implied fair value of about $91. This reflects modest adjustments to assumptions about the discount rate, revenue growth, and profit margins.Narrative Update • Jan 26
COO: Future Returns Will Lean On Myopia Management Expansion Potential
Analysts have nudged their price target for Cooper Companies slightly higher to about $91.06 from roughly $90.88, citing modestly stronger assumptions for revenue growth and profit margins, along with a somewhat lower future P/E multiple. What's in the News CooperVision plans to launch MyDay MiSight 1 day myopia control contact lenses in the UK and select European and surrounding markets, expanding its myopia management portfolio that uses ActivControl Technology and silicone hydrogel material from the MyDay family (Key Developments).Narrative Update • Jan 09
COO: Future Returns Will Balance Myopia Expansion With Activist Governance Pressure
Analysts have nudged their price target on Cooper Companies slightly higher to US$90.88 from US$90.50, reflecting small model adjustments in fair value estimates, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News CooperVision plans to launch MyDay MiSight 1 day myopia management contact lenses in the UK and select European and surrounding markets, combining its ActivControl Technology with MyDay silicone hydrogel material to target childhood myopia.Analysis Article • Jan 06
Is It Too Late To Consider Buying The Cooper Companies, Inc. (NASDAQ:COO)?
The Cooper Companies, Inc. ( NASDAQ:COO ) saw a significant share price rise of 22% in the past couple of months on the...Narrative Update • Dec 15
COO: Future Returns Will Balance Buybacks With Activist Governance Pressure
Narrative Update on Cooper Companies Analysts have raised their price target on Cooper Companies by 9 percent, from 83 dollars to 90.50 dollars. This reflects increased conviction in the company’s long term earnings power, despite slightly lower growth and margin assumptions, offset by a higher expected valuation multiple.Narrative Update • Dec 01
COO: Shareholder Value Will Be Driven by Buybacks Amid Leadership Pressure
Analysts have maintained their fair value estimate for Cooper Companies at $83.00, citing only minimal adjustments to growth and profitability assumptions in recent models. What's in the News On November 19, 2025, Browning West LP sent a letter to the Cooper Companies' board criticizing underperformance.Narrative Update • Nov 17
COO: Expanded Buyback Authorization Will Drive Shareholder Value Higher
Analysts have modestly revised their price target for Cooper Companies to $83.00. They cite slight adjustments in the discount rate and future valuation estimates, reflecting updated market expectations.Narrative Update • Nov 01
COO: Share Buybacks And Merger Potential Will Drive Undervalued Stock Higher
Analysts have maintained their price target for Cooper Companies at $83.00, citing stability in the company’s fundamental metrics and minimal changes in key financial assumptions. What's in the News Jana Partners LLC has urged Cooper Companies to consider strategic alternatives, including a potential merger of its contact lens unit with Bausch + Lomb Corp, and to improve capital allocation and shareholder returns (Key Developments).Narrative Update • Oct 17
Global Rollouts And Automation Will Revitalize Contact Lenses
Analysts have slightly lowered their price target for Cooper Companies from $83.19 to $83.00, citing minor adjustments in key financial metrics such as fair value and forward P/E ratio. What's in the News On September 17, 2025, Cooper Companies increased its equity buyback plan by $1,000 million, raising total authorization to $2,000 million (Key Developments).Narrative Update • Oct 03
Global Rollouts And Automation Will Revitalize Contact Lenses
Analysts have slightly lowered their price target for Cooper Companies from $84.47 to $83.19. They cite minor adjustments in projected revenue growth and profit margins as the reason for this change.Narrative Update • Aug 29
Expanding MyDay And MiSight Product Lines Will Meet Strong Market Demand
The consensus analyst price target for Cooper Companies has been revised downward, primarily reflecting a reduced future P/E multiple while revenue growth expectations remain stable, resulting in a new price target of $84.56. What's in the News Repurchased 724,300 shares for $52.1 million between May and July 2025; total buyback completed is 5,921,842 shares for $836.4 million (3.03% of shares outstanding).Analysis Article • Jul 21
Some Investors May Be Worried About Cooper Companies' (NASDAQ:COO) Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...Analysis Article • Jul 03
Market Participants Recognise The Cooper Companies, Inc.'s (NASDAQ:COO) Earnings
The Cooper Companies, Inc.'s ( NASDAQ:COO ) price-to-earnings (or "P/E") ratio of 35.2x might make it look like a...Analysis Article • Jun 15
Is It Time To Consider Buying The Cooper Companies, Inc. (NASDAQ:COO)?
Today we're going to take a look at the well-established The Cooper Companies, Inc. ( NASDAQ:COO ). The company's stock...Analysis Article • May 30
Does Cooper Companies (NASDAQ:COO) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Seeking Alpha • Mar 01
CooperCompanies: A Somewhat Less Demanding Valuation, But Some Added Growth Concerns
Summary CooperCompanies' Vision business has faced some recent concerns about growth, but long-term growth opportunities in toric lenses, dailies, myopia management, and fertility remain strong. Vision sales have been impacted by distributor inventory management and possibly a softer overall U.S. market, but growth should be bottoming and can reaccelerate on share growth across the business. The Fertility business is leveraged by a worldwide trend toward having children later in life, a growing global middle class, and governments improving fertility treatment reimbursement to encourage population growth. Despite strong EBITDA margins, Cooper has underwhelmed with free cash flow generation, but management is focused on improving this over the coming years. The stock's recent 20% pullback presents a potential buying opportunity, though some investors may want to wait for FQ1'25 results and guidance before stepping up. Read the full article on Seeking AlphaSeeking Alpha • Oct 09
The Cooper Companies: Winning Share In Contact Lens Markets
Summary I reiterate a ‘Buy’ rating for Cooper with a fair value of $120 per share due to their strong market share gains and strategic acquisitions. CooperVision's revenue grew 10% organically, driven by their focus on Torics, Multifocal, and daily disposable contact lenses, outpacing the market's 7% growth. Recent acquisitions of obp Surgica and ZyMōt Fertility align with Cooper’s M&A strategy, enhancing their technology in vision and fertility markets. Cooper’s pricing power and cost optimization efforts are expected to drive margin expansion, with projected total revenue growth of 9.5% annually. Read the full article on Seeking Alpha
New Narrative • Aug 29
Innovative Growth In Myopia Management And Fertility Boosts Future Prospects
Expansion in manufacturing and new product introductions alongside strategic R&D investments in myopia and fertility are driving growth and margins.Seeking Alpha • Aug 26
The Cooper Companies: Still An Expensive Place
Summary The Cooper Companies continues to pursue M&A to grow its CooperSurgical business. Over time, the company is finding a greater balance between this business and its core CooperVision segment. Cooper shares have been trading range bound for a long period of time, as shares are growing into a very premium valuation. Read the full article on Seeking AlphaSeeking Alpha • Jun 14
Cooper Companies: Business Growth Noted, Valuations An Ask
Summary The healthcare sector offers average value compared to the S&P 500 on a price-value basis. Cooper Companies, Inc. presents with robust business fundamentals but investors are pricing the company to perfection. Q1 FY 2024 earnings show strong growth, but the stock appears stretched at 26x forward earnings in my view. Read the full article on Seeking AlphaSeeking Alpha • Mar 22
The Cooper Companies: Rating Upgrade As Near-Term Momentum Should Continue
Summary The Cooper Companies stock saw a sharp reversion in share price, leading to a buy rating with an expected 8% return over 6 months. COO's recent results showed 8% growth in constant currency, beating revenue estimates, and raising guidance for FY24. COO is well-positioned to continue delivering growth above the market, with strong product fit and distribution capabilities, and potential for expansion in the myopia management segment. Read the full article on Seeking AlphaSeeking Alpha • Mar 01
The Cooper Companies: I Still Don't See Much Upside
Summary The Cooper Companies' shares rose 6.7% after reporting higher-than-expected revenue and adjusted earnings per share for the first quarter of fiscal year 2024. While the top line showed robust growth, the bottom line was mixed, with earnings per share falling short of expectations but adjusted earnings exceeding forecasts. The company expects continued growth in revenue for 2024, but the high share price and weakening bottom line suggest a cautious approach is warranted. Read the full article on Seeking AlphaShareholder Returns
| COO | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 1.1% | 0.08% | -0.3% |
| 1Y | -27.2% | -24.4% | 24.1% |
Return vs Industry: COO underperformed the US Medical Equipment industry which returned -24.4% over the past year.
Return vs Market: COO underperformed the US Market which returned 24.1% over the past year.
Price Volatility
| COO volatility | |
|---|---|
| COO Average Weekly Movement | 3.3% |
| Medical Equipment Industry Average Movement | 8.6% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: COO has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: COO's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | 15,000 | Al White | www.coopercos.com |
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia.
The Cooper Companies, Inc. Fundamentals Summary
| COO fundamental statistics | |
|---|---|
| Market cap | US$11.63b |
| Earnings (TTM) | US$401.40m |
| Revenue (TTM) | US$4.15b |
29.0x
P/E Ratio2.8x
P/S RatioIs COO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| COO income statement (TTM) | |
|---|---|
| Revenue | US$4.15b |
| Cost of Revenue | US$1.43b |
| Gross Profit | US$2.72b |
| Other Expenses | US$2.32b |
| Earnings | US$401.40m |
Last Reported Earnings
Jan 31, 2026
Next Earnings Date
Jun 04, 2026
| Earnings per share (EPS) | 2.06 |
| Gross Margin | 65.44% |
| Net Profit Margin | 9.67% |
| Debt/Equity Ratio | 29.9% |
How did COO perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/18 10:32 |
| End of Day Share Price | 2026/05/15 00:00 |
| Earnings | 2026/01/31 |
| Annual Earnings | 2025/10/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
The Cooper Companies, Inc. is covered by 29 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jeffrey Johnson | Baird |
| Matthew Miksic | Barclays |
| Joanne Wuensch | BMO Capital Markets Equity Research |